ATE498686T1 - Nicotin-acetylcholin rezeptoruntereinheit, deren isolierung und verwendung - Google Patents

Nicotin-acetylcholin rezeptoruntereinheit, deren isolierung und verwendung

Info

Publication number
ATE498686T1
ATE498686T1 AT00951509T AT00951509T ATE498686T1 AT E498686 T1 ATE498686 T1 AT E498686T1 AT 00951509 T AT00951509 T AT 00951509T AT 00951509 T AT00951509 T AT 00951509T AT E498686 T1 ATE498686 T1 AT E498686T1
Authority
AT
Austria
Prior art keywords
polypeptides
nicotine
isolation
acetylcholine receptor
receptor subunit
Prior art date
Application number
AT00951509T
Other languages
English (en)
Inventor
Francois Besnard
Eric Charpantier
Frederic Sgard
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE498686T1 publication Critical patent/ATE498686T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00951509T 1999-09-29 2000-08-08 Nicotin-acetylcholin rezeptoruntereinheit, deren isolierung und verwendung ATE498686T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99402371A EP1090991A1 (de) 1999-09-29 1999-09-29 Nikotin-acetylcholin-Rezeptor, dessen Isolierung und Verwendung
PCT/EP2000/007918 WO2001023551A1 (en) 1999-09-29 2000-08-08 Novel nicotinic acetylcholine receptor subunit, its isolation and use

Publications (1)

Publication Number Publication Date
ATE498686T1 true ATE498686T1 (de) 2011-03-15

Family

ID=8242126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00951509T ATE498686T1 (de) 1999-09-29 2000-08-08 Nicotin-acetylcholin rezeptoruntereinheit, deren isolierung und verwendung

Country Status (8)

Country Link
EP (2) EP1090991A1 (de)
AT (1) ATE498686T1 (de)
AU (1) AU6442000A (de)
DE (1) DE60045637D1 (de)
DK (1) DK1222265T3 (de)
ES (1) ES2358317T3 (de)
PT (1) PT1222265E (de)
WO (1) WO2001023551A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1190709A1 (de) * 2000-09-21 2002-03-27 Tinnitus Forschungs- und Entwicklungs GmbH Behandlung von Tinnitus
EP1190708A1 (de) * 2000-09-21 2002-03-27 Tinnitus Forschungs- und Entwicklungs GmbH Medizinische Verwendung von Verbindungen
JP5558817B2 (ja) * 2006-07-18 2014-07-23 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション 痛みの処置方法および鎮痛化合物のスクリーニング方法
US9284358B2 (en) 2006-07-18 2016-03-15 University Of Utah Research Foundation Conotoxin peptides
US12227771B2 (en) * 2019-05-17 2025-02-18 Janssen Pharmaceutica Nv Expression systems and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683912A (en) * 1994-07-21 1997-11-04 The Salk Institute For Biological Studies Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit
US5599709A (en) * 1989-09-28 1997-02-04 The Salk Institute For Biological Studies Recombinant DNA encoding neuronal α-bungarotoxin-binding proteins
US6485967B1 (en) * 1995-06-07 2002-11-26 Merck & Co., Inc. Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid

Also Published As

Publication number Publication date
EP1222265B1 (de) 2011-02-16
AU6442000A (en) 2001-04-30
DE60045637D1 (de) 2011-03-31
DK1222265T3 (da) 2011-06-06
WO2001023551A1 (en) 2001-04-05
EP1222265A1 (de) 2002-07-17
PT1222265E (pt) 2011-03-22
ES2358317T3 (es) 2011-05-09
EP1090991A1 (de) 2001-04-11

Similar Documents

Publication Publication Date Title
WO1998031799A3 (en) Polynucleotides and polypeptides encoding receptors
ATE396264T1 (de) Zytokinrezeptoruntereinheit-proteine aus säugetieren, damit zusammenhängende reagenzien und methoden
DE69941598D1 (de) Anti-ccr2 antikörper sowie deren verwendung
DE60009484D1 (de) Als ngf-antagonisten wirkende monoklonale antiköper und deren synthetische und biotechnologische derivate
DE60042066D1 (de) Chimärische dr4 antikörper und ihre verwendung
CY1109093T1 (el) Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι
EP1433792A3 (de) Menschlische-rezeptor Proteine; verwandte Reagenzien und Methoden
DE69938725D1 (de) Monoklonale antikörper gegen das protein g3bp und deren verwendungen
WO2003089603A3 (en) Cytokine receptor
MY141459A (en) Recombinant anti-idiotypic antibodies
ATE498686T1 (de) Nicotin-acetylcholin rezeptoruntereinheit, deren isolierung und verwendung
NO20000731D0 (no) Neisseria-lactodweeinbindingsprotein
ATE490271T1 (de) Rezeptor, dessen verwendung sowie mausantikörper
DK1122307T3 (da) Human carnosinase 2
WO2001068816A8 (en) Human histamine h3 gene variant-3
ATE299739T1 (de) Neurokinin b vorläufer aus menschlicher plazenta
WO2001068703A8 (en) Human histamine h3 gene variant-2
ATE525086T1 (de) Antikörper gegen thyrotropinrezeptor und ihre verwendungen
DK1309690T3 (da) MFQ-111, et humant GTPase-lignende protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1222265

Country of ref document: EP